Literature DB >> 24975174

Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients.

Teresa Chiacchio1, Elisa Petruccioli1, Valentina Vanini1, Gilda Cuzzi1, Carmela Pinnetti2, Alessandro Sampaolesi2, Andrea Antinori2, Enrico Girardi3, Delia Goletti4.   

Abstract

OBJECTIVES: Polyfunctional T-cells associate with chronic viral infection control while their involvement in tuberculosis (TB) is unclear. We evaluated TB-specific polyfunctional T-cell response and memory status in antiretroviral treatment (ART)-naïve HIV-infected patients from a low TB-endemic country.
METHODS: We prospectively enrolled HIV-infected patients, 12 with active TB (HIV-TB) and 15 with latent tuberculosis infection (LTBI). Peripheral blood cells were stimulated with TB antigens (RD1 proteins/peptides), HIV antigens, cytomegalovirus (CMV) and staphylococcal enterotoxin B (SEB) and analyzed by cytometry.
RESULTS: The HIV-TB showed a higher frequency of polyfunctional CD4(+) T-cells in response to RD1 antigens than HIV-LTBI (p = 0.007). Among the CD8(+) T-cells, both groups showed a significantly higher frequency of RD1-specific monofunctional cells than polyfunctional cells (p = 0.03). Analyzing the cytokine profile, IFNγ(+) TNFα(+) CD4(+) T-cells associated with HIV-TB (p ≤ 0.02) whereas IL2(+) TNFα(+) associated with HIV-LTBI (p = 0.009). CD4(+) T-cell response presented an effector-memory status in HIV-TB (p = 0.007) and an effector-memory terminally-differentiated phenotype in HIV-LTBI (p = 0.03). CD8(+) T-cell response presented an effector status in HIV-LTBI (p = 0.02). No significant cytokine profile pattern associated with responses to the other stimuli tested.
CONCLUSIONS: In HIV-infection, polyfunctional CD4(+) T-cell-response associates with active TB, characterized by a high proportion of IFNγ(+) TNFα(+) and an effector-memory phenotype.
Copyright © 2014 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  HIV; LTBI; Phenotype; Polyfunctional; Tuberculosis

Mesh:

Substances:

Year:  2014        PMID: 24975174     DOI: 10.1016/j.jinf.2014.06.009

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  36 in total

Review 1.  Fourth-Generation QuantiFERON-TB Gold Plus: What Is the Evidence?

Authors:  Arena Shafeque; Jacob Bigio; Catherine A Hogan; Madhukar Pai; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

2.  Specificity of QuantiFERON-TB Plus, a New-Generation Interferon Gamma Release Assay.

Authors:  S A R Siegel; M Cavanaugh; J H Ku; L M Kawamura; K L Winthrop
Journal:  J Clin Microbiol       Date:  2018-11-27       Impact factor: 5.948

3.  Quantitative Analysis of Gamma Interferon Release Assay Response in Children with Latent and Active Tuberculosis.

Authors:  Giulia Lombardi; Roberta Petrucci; Ilaria Corsini; Maria Letizia Bacchi Reggiani; Francesca Visciotti; Filippo Bernardi; Maria Paola Landini; Salvatore Cazzato; Paola Dal Monte
Journal:  J Clin Microbiol       Date:  2018-01-24       Impact factor: 5.948

4.  Activation Profile of Mycobacterium tuberculosis-Specific CD4(+) T Cells Reflects Disease Activity Irrespective of HIV Status.

Authors:  Katalin A Wilkinson; Tolu Oni; Hannah P Gideon; Rene Goliath; Robert J Wilkinson; Catherine Riou
Journal:  Am J Respir Crit Care Med       Date:  2016-06-01       Impact factor: 21.405

5.  Flow Cytometric Characterization of Antigen-Specific T Cells Based on RNA and Its Advantages in Detecting Infections and Immunological Disorders.

Authors:  Felix Radford; Sanjay Tyagi; Maria Laura Gennaro; Richard Pine; Yuri Bushkin
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

6.  Novel T-cell assays for the discrimination of active and latent tuberculosis infection: the diagnostic value of PPE family.

Authors:  Babak Pourakbari; Setareh Mamishi; Majid Marjani; Mehrnaz Rasulinejad; Sabrina Mariotti; Shima Mahmoudi
Journal:  Mol Diagn Ther       Date:  2015-10       Impact factor: 4.074

7.  Combined antigen-specific interferon-γ and interleukin-2 release assay (FluoroSpot) for the diagnosis of Mycobacterium tuberculosis infection.

Authors:  Dumitru Chesov; Christoph Lange; Franziska Daduna; Valeriu Crudu; Rosemarie Preyer; Martin Ernst; Barbara Kalsdorf
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

8.  Early dynamics of T helper cell cytokines and T regulatory cells in response to treatment of active Mycobacterium tuberculosis infection.

Authors:  S L Feruglio; K Tonby; D Kvale; A M Dyrhol-Riise
Journal:  Clin Exp Immunol       Date:  2015-03       Impact factor: 4.330

9.  High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine evaluation.

Authors:  Laura Sibley; Andrew D White; Karen E Gooch; Lisa M Stevens; Rachel Tanner; Ashley Jacobs; Owen Daykin-Pont; Fergus Gleeson; Anthony McIntyre; Randall Basaraba; Simon Clark; Graham Hall; Geoff Pearson; Emma Rayner; Helen McShane; Ann Williams; Mike Dennis; Philip D Marsh; Sally Sharpe
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.996

10.  Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection.

Authors:  Elisa Petruccioli; Teresa Chiacchio; Assunta Navarra; Valentina Vanini; Gilda Cuzzi; Claudia Cimaglia; Luigi Ruffo Codecasa; Carmela Pinnetti; Niccolò Riccardi; Fabrizio Palmieri; Andrea Antinori; Delia Goletti
Journal:  J Infect       Date:  2020-02-22       Impact factor: 6.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.